Search Results
Sahpra approves Section 21 use of Pfizer vaccine
COVID-19 Pandemic | SAHPRA approves section 21 emergency use for the Pfizer-BioNTech vaccine
SAHPRA CEO discusses approval of Pfizer Booster on eNCA
South African Regulator Approves Pfizer BioNTech Vaccine For Emergency Use | AFRICA
SAHPRA continues to monitor the safety risks of various COVID-19 vaccines
Sahpra Media Briefing on the status of the registration of COVID-19 vaccines in South Africa
Full media Briefing - Status of Covid vaccines registrations and approvals in South Africa
SAHPRA Covid-19 press conference
Press Conference: The process of vaccine approval media briefing
Webinar - Update on COVID-19 Therapies (21 February 2022)
Sisonke Study Interview with SAHPRA CEO on Newzroom Afrika
SAHPRA's media briefing on Ivermectin
